Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

12.73
BATS BZX Real-Time Price
As of 2:45pm ET
 -0.58 / -4.32%
Today’s Change
12.21
Today|||52-Week Range
25.46
-2.86%
Year-to-Date

Today’s Trading

Previous close13.30
Today’s open13.25
Day’s range12.55 - 13.30
Volume29,633
Average volume (3 months)821,498
Market cap$684.5M
Dividend yield--
Data as of 2:45pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-2.79%
Earnings growth (this year)-52.77%
Earnings growth (next 5 years)-19.63%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.07

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc-0.15-0.77%
ACIUAC Immune Ltd-0.20-1.59%
ACRSAclaris Therapeutics...-0.85-3.13%
LCILannett Company Inc-0.15-0.78%
Data as of 2:45pm ET, 01/23/2017

Financials

Next reporting dateApril 3, 2017
EPS forecast (this quarter)-$1.17
Annual revenue (last year)$0.00
Annual profit (last year)-$97.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts


Search for Jobs